Abstract:Therapeutic Advances in Drug Safety, Volume 15, Issue , January-December 2024. Background:Executing structured medication reviews (SMRs) in primary care to optimize drug treatment is considered standard care of community pharmacists in the Netherlands. Patients with Parkinson's disease (PD) often face complex drug regimens for their symptomatic treatment and might, therefore, benefit from an SMR. However, previously, no effect of an SMR on quality of life in PD was found. In trying to improve the case management of PD, it is interesting to understand if and to what extent SMRs in PD patients are of added value in the pharmacist's opinion and what are assumed facilitating and hindering factors.Objectives:To analyse the process of executing SMRs in PD patients from a community pharmacist's point of view.Design:A cross-sectional, qualitative study was performed, consisting of face-to-face semi-structured in-depth interviews.Methods:The interviews were conducted with community pharmacists who executed at least one SMR in PD, till data saturation was reached. Interviews were transcribed verbatim, coded and analysed thematically using an iterative approach.Results:Thirteen pharmacists were interviewed. SMRs in PD were considered of added value, especially regarding patient contact and bonding, individualized care and its possible effect in the future, although PD treatment is found already well monitored in secondary care. Major constraints were time, logistics and collaboration with medical specialists.Conclusion:Although community pharmacist-led SMRs are time-consuming and sometimes logistically challenging, they are of added value in primary care in general, and also in PD, of which treatment occurs mainly in secondary care. It emphasizes the pharmacist's role in PD treatment and might tackle future drug-related issues. Improvements concern multidisciplinary collaboration for optimized SMR execution and results.Plain language summaryStructured medication reviews in Parkinson's disease: pharmacists' views, experiences and needsWhy is this research done?In Parkinson's disease (PD), drug therapy is still the most important treatment strategy. Due to disease progression, patients often face complicated medication regimens, polypharmacy, and potential drug-related problems. The execution of structured medication reviews (SMR) in primary care is considered standard care of community pharmacists in the Netherlands, aiming to optimise drug treatment. Although it might also affect clinical outcomes, we found no effect of an SMR in PD on quality of life in our previous study. In trying to improve case management of PD, we need to understand if and to what extent SMRs in PD patients are of added value in the pharmacist's opinion, and what are assumed facilitating and hindering factors.What did the researchers do?We conducted semi-structured interviews with 13 community pharmacists who recently executed ⩾1 SMR in PD.What did the researchers find?We found that SMRs in PD are considered of added value with regard to patient bonding and individualised care. By being known by the pharmacist, and vice versa, by knowing the patient's situation, future drug problems might be tackled earlier. However, executing SMRs comes with barriers, of which lack of time, logistic constraints and difficulties in cooperation with the medical specialist are the most important.What do these findings mean?Taking into account both the pharmacist's effort and additional costs when performing an SMR in the current setting, the valuable time of a pharmacist could potentially better be spent on more (cost-)effective interventions, or a structural solution should be sought for the experienced hindering factors. Since we do not doubt the importance of periodic medication optimization in complex diseases or high-risk patients, we have to focus on either improving the current setting of SMRs in PD, or searching for other strategies in which this can be achieved.

L’accompagnement du patient parkinsonien en ambulatoire : élaboration et mise en œuvre d’entretiens pharmaceutiques

Iatrogénie médicamenteuse et recours au pharmacien d’officine : enquête auprès de patients atteints de la maladie de Parkinson

Évaluation par les neurologues et les patients de DigiPark, une application dédiée à la télésurveillance (TS) de la maladie de Parkinson (MP)

[Older patients and injectable anticancer drug: Feasibility study of the implementation of pharmaceutical interviews in oncogeriatrics in a hospital center]

Mise en place de consultations pharmaceutiques d'initiation en oncologie digestive dans un centre hospitalo-universitaire : bilan à 1 an

Structured medication reviews in Parkinson's disease: pharmacists' views, experiences and needs – a qualitative study

Programme de soins psychiatriques : Etude de l'expérience de jeunes patients par une méthode qualitative: Psychiatric care program: A qualitative study of the experience of young patients

Maladie de Parkinson et besoins en matière d’outils technologiques de soutien à la communication : étude qualitative

Application of clinical model which consisted of clinician and clinical pharmacists in compliance of patients with Parkinson's disease

Assistive products in pharmacy practice to optimize medications use for visually impaired patients: Focus groups to explore community pharmacists' opinions and expectations

Exemple dans un syndrome parkinsonien atypique : l’atrophie multisystématisée

Proposition paramédicale de recours en cas de poussée chez les patients atteints de sclérose en plaques par les compétences d’infirmiers en pratique avancée (IPA)

Stroke patients’ support: evaluation of knowledge, practices and training needs of French community pharmacists

Clinical impact of pharmaceutical consultations in patients treated for chronic obstructive pulmonary disease: Study protocol for a randomized controlled trial (BPCObs study)

Présentation du projet expérimental IRENE (Infirmières REférentes en NEurologie)

Descriptive study of general practitioner's practices and knowledge about Parkinson's disease in the north of France

ON/OFF non-motor evaluation: a new way to evaluate non-motor fluctuations in Parkinson’s disease

Enquête nationale auprès des malades sur la réadaptation respiratoire actuelle et future

Les actualités autour de la maladie de Parkinson

Amantadine use in the French prospective NS-Park cohort

Evaluation of an enhanced service for medication review with follow up in Swiss community pharmacies: Pre-post study protocol